Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Edinburgh International Conference Centre

May 26, 2016 2:00 PM - May 26, 2016 5:30 PM

The Exchange , Edinburgh EH3 8EE , Scotland , UNITED KINGDOM

TUTORIAL 01: EMA REGULATORY ROUTES SUPPORTING ORPHAN DRUG DEVELOPMENT

Instructors

Kristina  Larsson, MS

Kristina Larsson, MS

Head of Orphan Medicines, Division for Human Medicines Evidence Generation, European Medicines Agency, Netherlands

Kristina Larsson joined the orphan team of the EMA as the Head of Office in July 2014. Before that she spent 8 years as a scientific officer in the scientific advice team of the EMA in charge of the Scientific Advice Working Party secretariat. Before joining the agency she worked three years in clinical research for AstraZeneca in Mölndal, Sweden. Kristina has a master of Medicine in Pharmaceutical Bioscience from the University of Gothenburg.

Jordi  Llinares Garcia, MS

Jordi Llinares Garcia, MS

Head of Research and Innovation, European Medicines Agency, Netherlands

Dr Jordi Llinares is currently the Head of Research and Innovation at the European Medicines Agency (EMA). At the Agency he has had different posiitons including Head of Orphan Medicines, Scientific Support Development and, and Scientific and regualtory management between 2009 and 2020. Dr Llinares graduated as a Medical Doctor from the University of Barcelona and specialised (MIR) as clinical pharmacologist at Hospital Vall d’Hebron. He has a Masters in Science in Epidemiology from the London School of Hygiene and Tropical Medicine (London). Before joining the Agency he worked as clinical pharmacologist at Hospital de Sant Pau (Barcelona) and was member of the Ethics Committee of the IAS (Institut d’Assistencia Sanitaria).

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.